PMA

P100026: NEUROPACE RNS SYSTEM

FDA PMA · Implanted brain stimulator for epilepsy · NeuroPace, Inc.

Key facts

PMA number P100026
Trade name NEUROPACE RNS SYSTEM
Generic name Implanted brain stimulator for epilepsy
Applicant NeuroPace, Inc.
Owner/operator NeuroPace
Product code PFN
Approval date Nov 14, 2013
Docket number 12M-1488
Notice date Nov 25, 2013
Establishment registration 3004426659
FEI number 3004426659

At a glance

  • 10–99 Supplements
  • Aug 19, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals